{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:26:04Z","timestamp":1791321964690,"version":"4.3.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.steroids.2012.11.011","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:40:51Z","timestamp":1354149651000},"page":"576-582","source":"Crossref","is-referenced-by-count":50,"title":["Lessons from the dissection of the activation functions (AF-1 and AF-2) of the estrogen receptor alpha in vivo"],"prefix":"10.1016","volume":"78","author":[{"given":"Jean-Fran\u00e7ois","family":"Arnal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Abot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-C\u00e9cile","family":"Valera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Laurell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gourdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Lenfant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2012.11.011_b0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mam.2006.07.001","article-title":"Structure\u2013function relationship of estrogen receptor alpha and beta: impact on human health","volume":"27","author":"Ascenzi","year":"2006","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.steroids.2012.11.011_b0010","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1126\/science.1086185","article-title":"Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling","volume":"301","author":"Thornton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.steroids.2012.11.011_b0015","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/j.1460-2075.1986.tb04300.x","article-title":"The chicken oestrogen receptor sequence. Homology with verba and the human oestrogen and glucocorticoid receptors","volume":"5","author":"Krust","year":"1986","journal-title":"EMBO J"},{"key":"10.1016\/j.steroids.2012.11.011_b0020","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0092-8674(89)90031-7","article-title":"The human estrogen receptor has two independent nonacidic transcriptional activation functions","volume":"59","author":"Tora","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2012.11.011_b0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0092-8674(02)00641-4","article-title":"Combinatorial control of gene expression by nuclear receptors and coregulators","volume":"108","author":"McKenna","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2012.11.011_b0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/emboj\/17.3.765","article-title":"Different positioning of the ligand-binding domain helix 12 and the f domain of the estrogen receptor accounts for functional differences between agonists and antagonists","volume":"17","author":"Nichols","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.steroids.2012.11.011_b0035","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1210\/me.9.7.814","article-title":"The carboxy-terminal f domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists","volume":"9","author":"Montano","year":"1995","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1210\/me.2006-0203","article-title":"Identification of regions within the f domain of the human estrogen receptor alpha that are important for modulating transactivation and protein\u2013protein interactions","volume":"21","author":"Koide","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/er.20.3.358","article-title":"Estrogen receptor null mice. What have we learned and where will they lead us?","volume":"20","author":"Couse","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2012.11.011_b0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1476-5381.2011.01538.x","article-title":"From in vivo gene targeting of estrogen receptors to optimisation of their modulation in menopause","volume":"165","author":"Arnal","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.steroids.2012.11.011_b0055","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/en.2011-1470","article-title":"Minireview: recent advances in extranuclear steroid receptor actions","volume":"152","author":"Hammes","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2012.11.011_b0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1749-6632.2001.tb04004.x","article-title":"The past, present, and future of selective estrogen receptor modulation","volume":"949","author":"Jordan","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.steroids.2012.11.011_b0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1031","article-title":"Tamoxifen: a most unlikely pioneering medicine","volume":"2","author":"Jordan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.steroids.2012.11.011_b0070","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687\u20131717.","DOI":"10.1016\/S0140-6736(05)66544-0"},{"key":"10.1016\/j.steroids.2012.11.011_b0075","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.steroids.2012.11.011_b0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2009.05.033","article-title":"Coronary heart disease and menopause management: the swinging pendulum of HRT","volume":"207","author":"Stevenson","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.steroids.2012.11.011_b0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.steroids.2012.11.011_b0090","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women\u2019s health initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.steroids.2012.11.011_b0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.maturitas.2006.05.004","article-title":"Prior hormone therapy and breast cancer risk in the women\u2019s health initiative randomized trial of estrogen plus progestin","volume":"55","author":"Anderson","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2012.11.011_b0100","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1158\/0008-5472.CAN-11-3768","article-title":"Stromal ER-alpha promotes tumor growth by normalizing an increased angiogenesis","volume":"72","author":"Pequeux","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2012.11.011_b0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2012.11.011_b0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2011-08-371831","article-title":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha-signaling","volume":"119","author":"Seillet","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.steroids.2012.11.011_b0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199608153350701","article-title":"Postmenopausal estrogen and progestin use and the risk of cardiovascular disease","volume":"335","author":"Grodstein","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2012.11.011_b0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.maturitas.2005.02.016","article-title":"Controversies about HRT \u2013 lessons from monkey models","volume":"51","author":"Clarkson","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2012.11.011_b0125","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.100.16.1727","article-title":"The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits","volume":"100","author":"Holm","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2012.11.011_b0130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MOL.0b013e3282ef3bca","article-title":"Estrogens in vascular biology and disease: where do we stand today?","volume":"18","author":"Arnal","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.steroids.2012.11.011_b0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm0397-324","article-title":"Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm","volume":"3","author":"Miyagawa","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.steroids.2012.11.011_b0140","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/aje\/kwm214","article-title":"Hormones and heart disease in women: the timing hypothesis","volume":"166","author":"Barrett-Connor","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.steroids.2012.11.011_b0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.maturitas.2010.11.016","article-title":"Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?","volume":"68","author":"Lenfant","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2012.11.011_b0150","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1152\/jappl.2001.91.6.2776","article-title":"Invited review: pharmacogenetics of estrogen replacement therapy","volume":"91","author":"Herrington","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.steroids.2012.11.011_b0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2005.12.004","article-title":"Controversies regarding hormone therapy: insights from inflammation and hemostasis","volume":"70","author":"Koh","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.steroids.2012.11.011_b0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.21059","article-title":"Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use","volume":"83","author":"Pomp","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.steroids.2012.11.011_b0165","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the esther study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2012.11.011_b0170","doi-asserted-by":"crossref","first-page":"c2519","DOI":"10.1136\/bmj.c2519","article-title":"Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study","volume":"340","author":"Renoux","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.steroids.2012.11.011_b0175","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-01-405498","article-title":"Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the haematopoietic estrogen receptor alpha","author":"Valera","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.steroids.2012.11.011_b0180","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.physiol.67.040403.120151","article-title":"Regulation of signal transduction pathways by estrogen and progesterone","volume":"67","author":"Edwards","year":"2005","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.steroids.2012.11.011_b0185","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0092-8674(03)00934-6","article-title":"Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter","volume":"115","author":"Metivier","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2012.11.011_b0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1210\/me.8.1.21","article-title":"Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions","volume":"8","author":"Tzukerman","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0195","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/j.1460-2075.1990.tb07469.x","article-title":"Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen","volume":"9","author":"Berry","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.steroids.2012.11.011_b0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/er.2003-0023","article-title":"Coregulator function: a key to understanding tissue specificity of selective receptor modulators","volume":"25","author":"Smith","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2012.11.011_b0205","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1128\/MCB.20.7.2411-2422.2000","article-title":"A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen","volume":"20","author":"Knutti","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.steroids.2012.11.011_b0210","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1128\/MCB.19.8.5363","article-title":"Purification and identification of p68 rna helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha","volume":"19","author":"Endoh","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.steroids.2012.11.011_b0215","doi-asserted-by":"crossref","first-page":"23962","DOI":"10.1074\/jbc.M101041200","article-title":"The human homologue of the yeast DNA repair and TFIIH regulator MMS19 is an AF-1-specific coactivator of estrogen receptor","volume":"276","author":"Wu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2012.11.011_b0220","doi-asserted-by":"crossref","first-page":"15645","DOI":"10.1074\/jbc.M000042200","article-title":"P300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the n-terminal a\/b domains","volume":"275","author":"Kobayashi","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2012.11.011_b0225","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1210\/me.15.11.1953","article-title":"Synergism between eralpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the n- and c-terminal domains","volume":"15","author":"Metivier","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2009.03.025","article-title":"Membrane-initiated actions of estrogen on the endothelium","volume":"308","author":"Kim","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0235","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/me.2004-0390","article-title":"Integration of the extranuclear and nuclear actions of estrogen","volume":"19","author":"Levin","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0240","first-page":"719","article-title":"Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity","volume":"104","author":"Kousteni","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2012.11.011_b0245","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/er.2010-0016","article-title":"Cracking the estrogen receptor\u2019s posttranslational code in breast tumors","volume":"32","author":"Le Romancer","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.steroids.2012.11.011_b0250","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1074\/jbc.M205692200","article-title":"Proximal events in signaling by plasma membrane estrogen receptors","volume":"278","author":"Razandi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2012.11.011_b0255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1091\/mbc.E04-07-0547","article-title":"Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol","volume":"16","author":"Acconcia","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.steroids.2012.11.011_b0260","doi-asserted-by":"crossref","first-page":"14783","DOI":"10.1073\/pnas.192569699","article-title":"Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src\/Erk phosphorylation cascade","volume":"99","author":"Wong","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0265","doi-asserted-by":"crossref","first-page":"17126","DOI":"10.1073\/pnas.0407492101","article-title":"Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial no synthase by estrogen receptor alpha","volume":"101","author":"Lu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0270","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1126\/science.1112062","article-title":"Molecular and cellular basis of cardiovascular gender differences","volume":"308","author":"Mendelsohn","year":"2005","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.steroids.2012.11.011_b0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/13697130902986385","article-title":"Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging","volume":"12","author":"Simoncini","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.steroids.2012.11.011_b0280","doi-asserted-by":"crossref","first-page":"11162","DOI":"10.1073\/pnas.90.23.11162","article-title":"Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene","volume":"90","author":"Lubahn","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0285","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm0597-545","article-title":"Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice","volume":"3","author":"Iafrati","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.steroids.2012.11.011_b0290","doi-asserted-by":"crossref","first-page":"15133","DOI":"10.1073\/pnas.96.26.15133","article-title":"Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice","volume":"96","author":"Karas","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0295","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/hh1801.097239","article-title":"Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice","volume":"89","author":"Karas","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2012.11.011_b0300","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1242\/dev.127.19.4277","article-title":"Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes","volume":"127","author":"Dupont","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.steroids.2012.11.011_b0305","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.CIR.103.3.423","article-title":"Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta","volume":"103","author":"Brouchet","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2012.11.011_b0310","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/hh0402.105096","article-title":"Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor","volume":"90","author":"Darblade","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2012.11.011_b0315","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/01.RES.0000021114.92282.FA","article-title":"Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury","volume":"90","author":"Pare","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.steroids.2012.11.011_b0320","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/CIRCULATIONAHA.109.898445","article-title":"Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice","volume":"120","author":"Billon-Gales","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2012.11.011_b0325","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/me.9.11.1441","article-title":"Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene","volume":"9","author":"Couse","year":"1995","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0330","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1073\/pnas.042688499","article-title":"The AF-1 activation-function of eralpha may be dispensable to mediate the effect of estradiol on endothelial no production in mice","volume":"99","author":"Pendaries","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0335","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1172\/JCI38291","article-title":"Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice","volume":"120","author":"Chambliss","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2012.11.011_b0340","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1124\/jpet.104.082867","article-title":"The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-alpha agonists and is abolished by estrogen deprivation","volume":"313","author":"Bolego","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.steroids.2012.11.011_b0345","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.109.191221","article-title":"Estrogen receptors and endothelium","volume":"30","author":"Arnal","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.steroids.2012.11.011_b0350","doi-asserted-by":"crossref","first-page":"24172","DOI":"10.1074\/jbc.271.39.24172","article-title":"Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation","volume":"271","author":"McInerney","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2012.11.011_b0355","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1074\/jbc.270.16.9535","article-title":"Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells","volume":"270","author":"Metzger","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2012.11.011_b0360","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1073\/pnas.0808742106","article-title":"The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17{beta}-estradiol","volume":"106","author":"Billon-Gales","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0365","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/jme.0.0290281","article-title":"Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse","volume":"29","author":"Kos","year":"2002","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0370","doi-asserted-by":"crossref","first-page":"13311","DOI":"10.1073\/pnas.1105632108","article-title":"Activation function 2 (AF2) of estrogen receptor-{alpha} is required for the atheroprotective action of estradiol but not to accelerate endothelial healing","volume":"108","author":"Billon-Gales","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0375","doi-asserted-by":"crossref","first-page":"14986","DOI":"10.1073\/pnas.1109180108","article-title":"Estrogen receptor alpha AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators","volume":"108","author":"Arao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0380","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1073\/pnas.1100454108","article-title":"Roles of transactivating functions 1 and 2 of estrogen receptor-{alpha} in bone","volume":"108","author":"Borjesson","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0385","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1074\/jbc.M806249200","article-title":"Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse","volume":"284","author":"Pedram","year":"2009","journal-title":"J Biol Chem"},{"issue":"Suppl. A","key":"10.1016\/j.steroids.2012.11.011_b0390","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.genm.2008.03.005","article-title":"Genetic and pharmacologic strategies to determine the function of estrogen receptor alpha and estrogen receptor beta in cardiovascular system","volume":"5","author":"Arias-Loza","year":"2008","journal-title":"Gend Med"},{"key":"10.1016\/j.steroids.2012.11.011_b0395","doi-asserted-by":"crossref","first-page":"e003","DOI":"10.1621\/nrs.06003","article-title":"Estrogen receptor beta: an overview and update","volume":"6","author":"Zhao","year":"2008","journal-title":"Nucl Recept Signal"},{"key":"10.1016\/j.steroids.2012.11.011_b0400","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1073\/pnas.0712029105","article-title":"Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant","volume":"105","author":"Antal","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2012.11.011_b0405","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2826.2011.02206.x","article-title":"Roles for oestrogen receptor beta in adult brain function","volume":"24","author":"Handa","year":"2012","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0410","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1210\/me.2010-0154","article-title":"Estrogen receptor-beta prevents cardiac fibrosis","volume":"24","author":"Pedram","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0415","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jsbmb.2007.03.002","article-title":"Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ER alpha","volume":"104","author":"Gougelet","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2012.11.011_b0420","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/me.2009-0252","article-title":"Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection","volume":"24","author":"Charn","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2012.11.011_b0425","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1126\/science.1070442","article-title":"Biomedicine. Defining the \u201cs\u201d in serms","volume":"295","author":"Katzenellenbogen","year":"2002","journal-title":"Science"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X12003157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X12003157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T09:11:21Z","timestamp":1643706681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X12003157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0039128X12003157"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2012.11.011","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}